36. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials9 trials including 4328 patients.
A 21% shorter time to alleviation of all symptoms for oseltamivir versus placebo recipients (time ratio 0.79, 95% CI 0.74–0.85; p<0.0001). The median times to alleviation were 97.5 h for oseltamivir and 122.7 h for placebo groups.
Fewer lower respiratory tract complications requiring antibiotics more than 48 h after randomisation (risk ratio [RR] 0.56, 95% CI 0.42–0.75; p=0.0001; 4.9% oseltamivir vs 8.7% placebo;
Fewer admittances to hospital for any cause (RR 0.37, 95% CI 0.17–0.81; p=0.013; 0.6% oseltamivir, 1.7% placebo).Lancet 2015; 385: 1729–37